Birchview Capital, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $95 Million distributed in 71 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $15M, Kla Corp with a value of $14.2M, Corcept Therapeutics Inc with a value of $4.93M, Ovintiv Inc. with a value of $4.09M, and Acadia Pharmaceuticals Inc with a value of $4.05M.
Examining the 13F form we can see an decrease of $16M in the current position value, from $111M to 95M.
Birchview Capital, LP is based out at Burlington, VT
Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.
Portfolio value
$95 Million
Healthcare: $73.9 Million
Technology: $14.2 Million
Energy: $6.11 Million
Basic Materials: $781,000
Stock Holdings Table Market Cap. of $300 Millions to $2 Billions